These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19818743)

  • 1. Retrorsine, but not monocrotaline, is a mechanism-based inactivator of P450 3A4.
    Dai J; Zhang F; Zheng J
    Chem Biol Interact; 2010 Jan; 183(1):49-56. PubMed ID: 19818743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Study of Hepatotoxicity of Pyrrolizidine Alkaloids Retrorsine and Monocrotaline.
    Yang X; Li W; Sun Y; Guo X; Huang W; Peng Y; Zheng J
    Chem Res Toxicol; 2017 Feb; 30(2):532-539. PubMed ID: 28095673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparative metabolism of the four pyrrolizidine alkaloids, seneciphylline, retrorsine, monocrotaline, and trichodesmine in the isolated, perfused rat liver.
    Yan CC; Cooper RA; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Aug; 133(2):277-84. PubMed ID: 7645024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2C and CYP2B Mediated Metabolic Activation of Retrorsine in Cyp3a Knockout Mice.
    Pang X; Tang C; Kong F; Chen M; Chen X
    Curr Drug Metab; 2020; 21(13):1040-1051. PubMed ID: 33267758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism-based inactivation of cytochrome P450 3A4 by 4-ipomeanol.
    Alvarez-Diez TM; Zheng J
    Chem Res Toxicol; 2004 Feb; 17(2):150-7. PubMed ID: 14967002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of hepatic in vitro metabolism of the pyrrolizidine alkaloid senecionine in sheep and cattle.
    Duringer JM; Buhler DR; Craig AM
    Am J Vet Res; 2004 Nov; 65(11):1563-72. PubMed ID: 15566096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New glutathione conjugate of pyrrolizidine alkaloids produced by human cytosolic enzyme-dependent reactions in vitro.
    Muluneh F; Häkkinen MR; El-Dairi R; Pasanen M; Juvonen RO
    Rapid Commun Mass Spectrom; 2018 Aug; 32(16):1344-1352. PubMed ID: 29788543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico prediction of the site of oxidation by cytochrome P450 3A4 that leads to the formation of the toxic metabolites of pyrrolizidine alkaloids.
    Fashe MM; Juvonen RO; Petsalo A; Vepsäläinen J; Pasanen M; Rahnasto-Rilla M
    Chem Res Toxicol; 2015 Apr; 28(4):702-10. PubMed ID: 25651456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal exposure to pyrrolizidine alkaloids induced hepatotoxicity and pulmonary injury in fetal rats.
    Guo Y; Xiao D; Yang X; Zheng J; Hu S; Wu P; Li X; Kou H; Wang H
    Reprod Toxicol; 2019 Apr; 85():34-41. PubMed ID: 30771476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photochromic agents as tools for protein structure study: lapachenole is a photoaffinity ligand of cytochrome P450 3A4.
    Gartner CA; Wen B; Wan J; Becker RS; Jones G; Gygi SP; Nelson SD
    Biochemistry; 2005 Feb; 44(6):1846-55. PubMed ID: 15697210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism-based inactivation of human recombinant P450 2C9 by the nonsteroidal anti-inflammatory drug suprofen.
    O'Donnell JP; Dalvie DK; Kalgutkar AS; Obach RS
    Drug Metab Dispos; 2003 Nov; 31(11):1369-77. PubMed ID: 14570769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of inactivation of human cytochrome P450 2B6 by phencyclidine.
    Jushchyshyn MI; Wahlstrom JL; Hollenberg PF; Wienkers LC
    Drug Metab Dispos; 2006 Sep; 34(9):1523-9. PubMed ID: 16782764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of astrocytic CYP1A1 isoform in the metabolism and toxicity of the alkaloid pyrrolizidine monocrotaline.
    Nascimento RP; Oliveira JL; Carvalho JLC; Santos WA; Pires TRC; Batatinha MJM; El-Bachá RS; Silva VDA; Costa SL
    Toxicon; 2017 Aug; 134():41-49. PubMed ID: 28400261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel glutathione conjugate of flutamide in incubations with human liver microsomes.
    Kang P; Dalvie D; Smith E; Zhou S; Deese A
    Drug Metab Dispos; 2007 Jul; 35(7):1081-8. PubMed ID: 17403914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activation of pyrrolizidine alkaloids by human, rat and avocado microsomes.
    Couet CE; Hopley J; Hanley AB
    Toxicon; 1996 Sep; 34(9):1058-61. PubMed ID: 8896199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation of nevirapine in human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4.
    Wen B; Chen Y; Fitch WL
    Drug Metab Dispos; 2009 Jul; 37(7):1557-62. PubMed ID: 19364830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
    Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF
    Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of cytochrome P450 (P450) 3A4 but not P450 3A5 by OSI-930, a thiophene-containing anticancer drug.
    Lin HL; Zhang H; Medower C; Hollenberg PF; Johnson WW
    Drug Metab Dispos; 2011 Feb; 39(2):345-50. PubMed ID: 21068193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac.
    Tang W; Stearns RA; Wang RW; Chiu SH; Baillie TA
    Chem Res Toxicol; 1999 Feb; 12(2):192-9. PubMed ID: 10027798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.